At a glance
ClinicalIndex Comparison RecordN/ACompleted· 102 enrolled
Drug / intervention
Radiesse® Injectable Dermal Filler with Lidocaine +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of Pain With the Use of Radiesse® With Lidocaine for the Treatment of Nasolabial Folds
In Brief
A clinical study evaluating Radiesse® Injectable Dermal Filler with Lidocaine and Radiesse® Injectable Dermal Filler without Lidocaine for Nasolabial Folds. Completed, enrolled 102 participants across 2 sites.
Detailed Summary
To assess pain during nasolabial fold treatment using Radiesse® Injectable Dermal Filler with lidocaine
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNasolabial Folds
CountriesCanada
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 2010
Enrollment StartNov 2012
Primary CompletionMay 2013
Study CompletionFeb 2014
TodayJul 2026
First PostedFeb 17, 2010
Enrollment StartNov 1, 2012
Primary CompletionMay 1, 2013
Study CompletionFeb 1, 2014
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 16.4 years ago
Interventions
Radiesse® Injectable Dermal Filler with Lidocainedevice
Calcium hydroxylapatite particles suspended in an aqueous-based gel carrier with 3% lidocaine hydrochloride (HCl)
Radiesse® Injectable Dermal Filler without Lidocainedevice
Calcium hydroxylapatite particles suspended in an aqueous-based gel carrier without 3% lidocaine hydrochloride (HCl)